US Markets
Home›US Markets›Sectors›DexCom shares lag the healthcare ETF over the past 52…
DexCom shares lag the healthcare ETF over the past 52 weeks
Despite a strong 3-month run, the article notes DexCom is still down relative to the State Street Health Select Sector SPDR ETF over 52 weeks.
DexCom, a San Diego-based medical technology company focused on continuous glucose monitoring, has a market capitalization of $33.2 billion, and its stock has shown mixed performance versus the healthcare sector, according to Yahoo Finance.
The article says DexCom shares have slipped 5.1% from their 52-week high of $92.59 reached on August 24, 2026, while climbing 21.1% over the past three months. Over that same three-month period, the State Street Health Select Sector SPDR ETF, XLV, gained 12.7%.
Year to date, DexCom has risen 32.4%, outpacing XLV's 10.8% gain, but over the past 52 weeks DexCom is up 8.8% versus XLV's 24.8% return, the piece adds. It also notes the stock has traded above its 50-day and 200-day moving averages since mid-May.
Yahoo Finance further points to a recent catalyst, saying DexCom shares surged about 12% on July 31 after the company reported Q2 results. The article states revenue increased 13.1% year over year to $1.31 billion, beating forecasts for $1.29 billion, and non-GAAP net income per share rose to 70 cents versus an expected 61 cents.